| Financial Year |
March 31 2023 |
| Monetary Funds |
821,705,741.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
103,011,510.00 |
| Accounts Receivable |
247,435,532.26 |
| Advances to Suppliers |
141,262,464.43 |
| Other Receivables |
74,745,184.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
332,790,972.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,279,299.14 |
| Total Current Assets |
1,749,230,704.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
172,293,838.52 |
| Investment Properties |
-- |
| Fixed Assetes |
1,480,030,272.27 |
| Under-construction Projects |
76,210,178.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
330,827,784.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
83,521,449.47 |
| Deferred Income Tax Assets |
32,242,835.57 |
| Other Non-Current Assets |
44,173,688.67 |
| Sub-Total of Non-Current Assets |
2,689,376,252.76 |
| Total Assets |
4,438,606,957.60 |
| Short-Term Loans |
485,271,181.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
141,866,815.76 |
| Accounts Payable |
110,281,428.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,352,342.73 |
| Taxes Payable |
16,409,913.31 |
| Interest Payable |
-- |
| Dividend Payable |
83,627,201.20 |
| Other payables |
308,178,781.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
198,160,006.90 |
| Other Current Liabilities |
7,503,958.62 |
| Sub-Total of Current Liabilities |
1,375,141,126.47 |
| Long-term Loans |
281,177,551.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
579,860,759.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,427,839.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,066,809,426.49 |
| Total Liabilities |
2,441,950,552.96 |
| Paid-In Capital(Or Share Stock) |
806,400,000.00 |
| Capital Surplus |
220,442,621.31 |
| Surplus Reserve |
228,601,541.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
581,853,078.33 |
| Minority Stockholder's Interest |
166,576,346.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,830,080,058.28 |
| Owner's Equity（Stockholder's Equity） |
1,996,656,404.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,438,606,957.60 |
